This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Age Beverages (NBEV) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
New Age Beverages (NBEV) first-quarter 2019 results are likely to benefit from brand strength and the Morinda buyout.
AB InBev (BUD) Q1 Earnings Miss, Sales Beat on Strong Volume
by Zacks Equity Research
AB InBev (BUD) reports strong organic sales growth and top-line beat in first-quarter 2019 on strong volume growth, global premiumization and ongoing revenue-management initiatives.
Monster Beverage (MNST) Surges on Q1 Earnings & Sales Beat
by Zacks Equity Research
Monster Beverage (MNST) posts top and bottom-line beat in first-quarter 2019, driven by strong sales for the Monster Energy brand energy drinks and the launch of Reign Total Body Fuel.
New Age Beverage Corporation (NBEV) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
New Age Beverage Corporation (NBEV) closed the most recent trading day at $5.47, moving -0.91% from the previous trading session.
Has New Age Beverage (NBEV) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NBEV) Outperforming Other Consumer Staples Stocks This Year?
Boston Beer (SAM) Rises on Q1 Earnings Beat, Strong Shipments
by Zacks Equity Research
Boston Beer's (SAM) first-quarter earnings and sales gain from strong shipment volume and depletions growth. The company perks up shipments and depletions view for 2019.
New Age Beverage Corporation (NBEV) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
New Age Beverage Corporation (NBEV) closed at $5.24 in the latest trading session, marking a -0.57% move from the prior day.
Coca-Cola (KO) Stock Rises on Q1 Earnings and Sales Beat
by Zacks Equity Research
Coca-Cola's (KO) first-quarter earnings and sales top estimates, benefiting from organic revenue growth across all segments as well as execution of growth strategies.
New Age Beverage Corporation (NBEV) Gains As Market Dips: What You Should Know
by Zacks Equity Research
New Age Beverage Corporation (NBEV) closed the most recent trading day at $5.26, moving +1.15% from the previous trading session.
PepsiCo (PEP) Q1 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
PepsiCo's (PEP) first-quarter 2019 results gain from strong operating performance at international divisions, and North America snacks and beverage businesses. The company reiterates view for 2019.
PepsiCo Closes CytoSport Buyout, Fortifies Nutrition Portfolio
by Zacks Equity Research
PepsiCo (PEP) buys the CytoSport business from Hormel Foods for $465 million. Muscle Milk and Evolve brands are likely to enhance PepsiCo's nutrition portfolio.
Do Options Traders Know Something About New Age Beverages (NBEV) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to New Age Beverages (NBEV) stock based on the movements in the options market lately.
New Age Beverage Corporation (NBEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
New Age Beverage Corporation (NBEV) closed the most recent trading day at $5.38, moving -1.47% from the previous trading session.
New Age Beverage Corporation (NBEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, New Age Beverage Corporation (NBEV) closed at $5.10, marking a -1.92% move from the previous day.
Soft Drinks Outlook: Can Portfolio Shift Bring Back the Fizz?
by Zacks Equity Research
The soft drinks space continues to struggle due to higher costs and soft carbonated-drinks sales. Meanwhile, companies' efforts to skew their portfolio toward health drinks and juices should help.
New Age Beverage Corporation (NBEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
New Age Beverage Corporation (NBEV) closed the most recent trading day at $6.31, moving -0.94% from the previous trading session.
PepsiCo (PEP) Q4 Earnings In Line, Sales Beat Estimates
by Zacks Equity Research
PepsiCo (PEP) reports in-line earnings in fourth-quarter 2018 while sales top estimates. Strong performances in international divisions, along with strength in FLNA and NAB segments, boost results.
Coca-Cola (KO) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Coca-Cola (KO) delivers in-line earnings and sales in fourth-quarter 2018. However, concerns regarding increased impacts of currency fluctuations are likely to mar results in 2019.
What to Expect From These 5 Soft Drinks Stocks' Q4 Earnings?
by Zacks Equity Research
Let's see what is in store for a few soft drinks beverage stocks that are lined up for earnings releases this week.
Bear of the Day: Cott (COT)
by David Bartosiak
Despite coming up off the lows, Cott has a long way to go to lure in long-term investors with solid growth numbers.
Earnings from Netflix & Big Banks, & This Week in Cannabis Deals
by Ryan McQueeney
Ryan McQueeney and Maddy Johnson discuss earnings results from Netflix and the big U.S. banks. The hosts also remember the legacy of Jack Bogle and chat about several new cannabis industry deals.
A Week of Cannabis Investing Deals & Earnings Reports from GS, BAC, UAL
by Ryan McQueeney
Ryan McQueeney covers the latest Brexit news and Snap's executive exodus. He also recaps earnings results from Goldman Sachs, Bank of America, and United Air Lines. Later, he discusses a busy week for deals in the cannabis industry.
Are Options Traders Betting on a Big Move in New Age Beverages (NBEV) Stock?
by Zacks Equity Research
Investors need to pay close attention to New Age Beverages (NBEV) stock based on the movements in the options market lately.
This Week's Top Tech Earnings and Today's Trending Stocks: PTI & NBEV
by Ryan McQueeney
Ryan McQueeney discusses concerns about slowing economic growth in China and a major court ruling affecting healthcare stocks. He also highlights trending stocks Proteostasis Therapeutics and New Age Beverages. Later, he previews earnings from Red Hat, Oracle, and Micron.
UAA Sputters, Hemp Stocks Jump, & Robinhood Takes on Banks
by Ryan McQueeney
Ryan McQueeney and Maddy Johnson discuss the latest trade war news, Under Armour's investor day, hemp legalization, and Robinhood's checking and savings accounts.